Marek Dróżdż
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marek Dróżdż has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Wiktoria Boral
F. Ceynowa Specialist Hospital in Wejherowo A. Jagalskiego 10, 84-200 Wejherowo
8 shared publications - Jan Puliński
Szpital Specjalistyczny im. Floriana Ceynowy, Wejherowo, Poland
6 shared publications - Wiktoria Marzec
Specialist Hospital named after Florian Ceynowy in Wejherowo, Wejherowo, Poland
6 shared publications - Alicja Czyszczoń5 shared publications
- Aleksandra Przelaskowska
Specialist Hospital named after F. Ceynowa in Wejherowo Dr.A Jagalskiego 10 84-200 Wejherowo Poland
4 shared publications - Aneta Tkaczyk
Podhalański Szpital Specjalistyczny w Nowym Targu
4 shared publications
Latest Publications
- Open Access
- 24 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50, 67855
Diabetic Retinopathy: Pathogenesis, Clinical Features and the Role of Physical Activity in Prevention and Management
Background Diabetic retinopathy (DR) is a vision-threatening microvascular complication of diabetes mellitus that affects the retina and is classified into non-proliferative (NDPR) and proliferative (PDR) forms with diabetic macular edema (DME) representing an additional sight-threatening manifestation. Aim This study provides a comprehensive overview of diabetic retinopathy, integrating current knowledge of its pathogenesis, risk factors, clinical features, diagnostic methods, treatment options and potential impact of physical activity on disease prevention and progression. Material and methods This study was conducted as a review of the selected literature on diabetic retinopathy available in the PubMed database. Keywords included “Diabetic retinopathy”, “Nonproliferative diabetic retinopathy”, “Proliferative diabetic retinopathy”, “Glycemic control”, “ Physical activity”. Results Diabetic retinopathy can remain asymptomatic for long periods, making regular eye examinations essential for its early detection. Strict control of blood glucose and blood pressure helps prevent the onset and slow the progression of diabetic retinopathy with inflammation playing a central role in its pathogenesis. In addition, physical activity is associated with a reduced risk of DR with a particularly strong protective effect against vision-threatening diabetic retinopathy (VTDR). Current treatments include intravitreal corticosteroids, anti-VEGF agents, vitrectomy and laser photocoagulation. Early diagnosis combined with optimized management can significantly reduce the risk of permanent visual loss. Conclusion Diabetic retinopathy is a primary contributor to vision loss in working-age adults in developed countries. Growing insights into its pathogenesis and the discovery of new therapeutic targets offer promising opportunities for improved treatment.
- 24 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50, 67855
Open AccessDiabetic Retinopathy: Pathogenesis, Clinical Features and the Role of Physical Activity in Prevention and Management
Background Diabetic retinopathy (DR) is a vision-threatening microvascular complication of diabetes mellitus that affects the retina and is classified into non-proliferative (NDPR) and proliferative (PDR) forms with diabetic macular edema (DME) representing an additional sight-threatening manifestation. Aim This study provides a comprehensive overview of diabetic retinopathy, integrating current knowledge of its pathogenesis, risk factors, clinical features, diagnostic methods, treatment options and potential impact of physical activity on disease prevention and progression. Material and methods This study was conducted as a review of the selected literature on diabetic retinopathy available in the PubMed database. Keywords included “Diabetic retinopathy”, “Nonproliferative diabetic retinopathy”, “Proliferative diabetic retinopathy”, “Glycemic control”, “ Physical activity”. Results Diabetic retinopathy can remain asymptomatic for long periods, making regular eye examinations essential for its early detection. Strict control of blood glucose and blood pressure helps prevent the onset and slow the progression of diabetic retinopathy with inflammation playing a central role in its pathogenesis. In addition, physical activity is associated with a reduced risk of DR with a particularly strong protective effect against vision-threatening diabetic retinopathy (VTDR). Current treatments include intravitreal corticosteroids, anti-VEGF agents, vitrectomy and laser photocoagulation. Early diagnosis combined with optimized management can significantly reduce the risk of permanent visual loss. Conclusion Diabetic retinopathy is a primary contributor to vision loss in working-age adults in developed countries. Growing insights into its pathogenesis and the discovery of new therapeutic targets offer promising opportunities for improved treatment.
- Open Access
- 17 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49, 67655
The use of ambroxol in various fields of medicine outside medical indications - A Review of the Current Literature
Introduction: Ambroxol is a drug that has a multifaceted application in medicine. Its main effects are mucolytic, mucokinetic, anti-inflammatory, antioxidant and local anesthetic. Ambroxol is used in various fields of medicine, including in the treatment of respiratory diseases, supporting the production of surfactant, treating sore throat and neuropathic pain. Ambroxol has been identified as a component that enhances the enzymatic activity of mutated glucocerebrosidase resulting from various mutations resulting from misfolding mutations in the GBA gene [1]. Experimental studies are also underway on the treatment of neurodegenerative diseases such as Parkinson's disease, amyotrophic lateral sclerosis as well as in the treatment of stroke and inhibition of Clostridioides difficile toxins TcdA and TcdB. This article highlights the variety of applications of ambroxol, which was initially used only in respiratory diseases. Study Objective: The aim of this article is to comprehensively review the literature on the use of ambroxol in various fields of medicine in order to expand the research and use of ambroxol in diseases beyond its registered indications. Materials and Methods: Electronic database including PubMed, science networks, Google Scholar, to identify studies and literature reviews on the use of ambroxol in various fields of medicine. State of the Art: This review examines the use of ambroxol beyond its medical indications, mainly emphasizing its use in neuropathic pain, Parkinson's disease, amyotrophic lateral sclerosis, Gaucher's disease. Attention is also paid to its use in stroke patients and in the inhibition of Clostridioides difficile toxins TcdA and TcdB. Conclusion: Ambroxol is an antitussive drug that has been used for years. More and more studies are available on the use of ambroxol beyond its medical indications, which show the validity of the concept of its use in other fields of medicine than respiratory diseases.
- 17 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49, 67655
Open AccessThe use of ambroxol in various fields of medicine outside medical indications - A Review of the Current Literature
Introduction: Ambroxol is a drug that has a multifaceted application in medicine. Its main effects are mucolytic, mucokinetic, anti-inflammatory, antioxidant and local anesthetic. Ambroxol is used in various fields of medicine, including in the treatment of respiratory diseases, supporting the production of surfactant, treating sore throat and neuropathic pain. Ambroxol has been identified as a component that enhances the enzymatic activity of mutated glucocerebrosidase resulting from various mutations resulting from misfolding mutations in the GBA gene [1]. Experimental studies are also underway on the treatment of neurodegenerative diseases such as Parkinson's disease, amyotrophic lateral sclerosis as well as in the treatment of stroke and inhibition of Clostridioides difficile toxins TcdA and TcdB. This article highlights the variety of applications of ambroxol, which was initially used only in respiratory diseases. Study Objective: The aim of this article is to comprehensively review the literature on the use of ambroxol in various fields of medicine in order to expand the research and use of ambroxol in diseases beyond its registered indications. Materials and Methods: Electronic database including PubMed, science networks, Google Scholar, to identify studies and literature reviews on the use of ambroxol in various fields of medicine. State of the Art: This review examines the use of ambroxol beyond its medical indications, mainly emphasizing its use in neuropathic pain, Parkinson's disease, amyotrophic lateral sclerosis, Gaucher's disease. Attention is also paid to its use in stroke patients and in the inhibition of Clostridioides difficile toxins TcdA and TcdB. Conclusion: Ambroxol is an antitussive drug that has been used for years. More and more studies are available on the use of ambroxol beyond its medical indications, which show the validity of the concept of its use in other fields of medicine than respiratory diseases.
- Open Access
- 12 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 87, 67848
The Effect of Polyphenol Supplementation on Recovery Following High-Intensity Interval Training
Polyphenols are a diverse group of plant-derived compounds. As a part of the human diet, they have a broad spectrum of biological activity, including antioxidant, anti-inflammatory, and immunomodulatory properties through multiple metabolic pathways. High-intensity interval training (HIIT) exercise, although widely used to improve physical performance, is associated with causing substantial metabolic and oxidative stress, inflammation, hormonal imbalance, and muscle damage. Some studies indicate that polyphenol intake may inhibit reactive oxygen species formation, modulate cytokine release, lower lipid peroxidation and damage of deoxyribonucleic acid, and improve markers of muscle recovery, potentially accelerating recovery after HIIT. However, other research contradicts the positive impact of polyphenol supplementation on recovery or performance.
- 12 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 87, 67848
Open AccessThe Effect of Polyphenol Supplementation on Recovery Following High-Intensity Interval Training
Polyphenols are a diverse group of plant-derived compounds. As a part of the human diet, they have a broad spectrum of biological activity, including antioxidant, anti-inflammatory, and immunomodulatory properties through multiple metabolic pathways. High-intensity interval training (HIIT) exercise, although widely used to improve physical performance, is associated with causing substantial metabolic and oxidative stress, inflammation, hormonal imbalance, and muscle damage. Some studies indicate that polyphenol intake may inhibit reactive oxygen species formation, modulate cytokine release, lower lipid peroxidation and damage of deoxyribonucleic acid, and improve markers of muscle recovery, potentially accelerating recovery after HIIT. However, other research contradicts the positive impact of polyphenol supplementation on recovery or performance.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
SPORT-RELATED DYSTONIA – CURRENT STATE OF KNOWLEDGE IN DIAGNOSIS AND TREATMENT
Sports-related dystonia (SRD) is believed to arise as a consequence of repetitive motor activity, often involving tens of thousands of movement repetitions performed during high-level athletic training. Professional sports practice is characterized by prolonged physical exertion and the frequent execution of specific motor tasks, repeated hundreds or even thousands of times in pursuit of technical perfection. This intensive regimen may lead to both physical and mental fatigue, potentially resulting in overuse injuries. SRD has been most frequently described in golfers, runners, cricketers, basketball players, and gymnasts. Despite growing awareness of its clinical presentation, SRD remains a diagnostic and therapeutic challenge.The aim of this study is to provide a comprehensive review of the current state of knowledge regarding SRD, based on publications available in the PubMed database.A literature search was conducted using relevant keywords to identify scientific publications not older than five years, retrieved from academic databases. SRD represents a complex clinical syndrome that requires a multidisciplinary and individualized approach. The absence of specific diagnostic tests, combined with the variability and subtlety of symptoms, often results in significant diagnostic challenges. Effective treatment must be tailored to the specific symptom profile presented by each athlete, taking into account both motor and non-motor aspects of the condition. Currently, further research is needed to improve both the diagnostic criteria and therapeutic strategies for managing SRD. Early identification and preventive strategies—particularly in young athletes—should be emphasized. Educational efforts aimed at raising awareness of the potential career-threatening nature of SRD may facilitate earlier recognition of symptoms and help prevent premature discontinuation of athletic careers.Treatment of this disorder must be individualized and focused on the specific range of symptoms present in each athlete. Currently, further research on the diagnosis and therapeutic options for patients affected by this condition is necessary.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Open AccessSPORT-RELATED DYSTONIA – CURRENT STATE OF KNOWLEDGE IN DIAGNOSIS AND TREATMENT
Sports-related dystonia (SRD) is believed to arise as a consequence of repetitive motor activity, often involving tens of thousands of movement repetitions performed during high-level athletic training. Professional sports practice is characterized by prolonged physical exertion and the frequent execution of specific motor tasks, repeated hundreds or even thousands of times in pursuit of technical perfection. This intensive regimen may lead to both physical and mental fatigue, potentially resulting in overuse injuries. SRD has been most frequently described in golfers, runners, cricketers, basketball players, and gymnasts. Despite growing awareness of its clinical presentation, SRD remains a diagnostic and therapeutic challenge.The aim of this study is to provide a comprehensive review of the current state of knowledge regarding SRD, based on publications available in the PubMed database.A literature search was conducted using relevant keywords to identify scientific publications not older than five years, retrieved from academic databases. SRD represents a complex clinical syndrome that requires a multidisciplinary and individualized approach. The absence of specific diagnostic tests, combined with the variability and subtlety of symptoms, often results in significant diagnostic challenges. Effective treatment must be tailored to the specific symptom profile presented by each athlete, taking into account both motor and non-motor aspects of the condition. Currently, further research is needed to improve both the diagnostic criteria and therapeutic strategies for managing SRD. Early identification and preventive strategies—particularly in young athletes—should be emphasized. Educational efforts aimed at raising awareness of the potential career-threatening nature of SRD may facilitate earlier recognition of symptoms and help prevent premature discontinuation of athletic careers.Treatment of this disorder must be individualized and focused on the specific range of symptoms present in each athlete. Currently, further research on the diagnosis and therapeutic options for patients affected by this condition is necessary.
- Open Access
- 25 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 81
Celiac Disease as an Underlying Cause of Multisystemic Symptoms: Consequences of Delayed Diagnosis - A Literature Review
Introduction and purpose Celiac disease (CD) is an autoimmune disorder that develops in genetically predisposed individuals in response to gluten intake. The overall prevalence of CD is approximately 0.75% in the general population, making it a condition frequently encountered in everyday clinical practice. CD impacts multiple organ systems. This paper describes its influence on, among others, the skin and mucous membranes, hematological parameters, bone health, reproductive function, and neuropsychiatric status. This review aims to summarize current evidence on the extraintestinal manifestations of this condition and highlight the importance of early recognition of these diverse symptoms. A brief description of the state of knowledge A comprehensive literature review was conducted using PubMed and MDPI databases. The analysis included original articles, reviews, and meta-analyses related to extraintestinal symptoms of CD, with emphasis on publications from the last ten years. The findings suggest that such symptoms are common and frequently non-specific, which frequently contributes to diagnostic delays. Many of them may occur before gastrointestinal symptoms or appear as isolated signs, leading to underdiagnosis and untreated disease. Summary Many extraintestinal symptoms of CD are still overlooked by clinicians. Improving healthcare professionals’ awareness of these symptoms may lead to earlier diagnosis and earlier initiation of a gluten-free diet. Timely treatment can help avoid long-term complications and significantly improve patients’ prognosis and quality of life.
- 25 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 81
Open AccessCeliac Disease as an Underlying Cause of Multisystemic Symptoms: Consequences of Delayed Diagnosis - A Literature Review
Introduction and purpose Celiac disease (CD) is an autoimmune disorder that develops in genetically predisposed individuals in response to gluten intake. The overall prevalence of CD is approximately 0.75% in the general population, making it a condition frequently encountered in everyday clinical practice. CD impacts multiple organ systems. This paper describes its influence on, among others, the skin and mucous membranes, hematological parameters, bone health, reproductive function, and neuropsychiatric status. This review aims to summarize current evidence on the extraintestinal manifestations of this condition and highlight the importance of early recognition of these diverse symptoms. A brief description of the state of knowledge A comprehensive literature review was conducted using PubMed and MDPI databases. The analysis included original articles, reviews, and meta-analyses related to extraintestinal symptoms of CD, with emphasis on publications from the last ten years. The findings suggest that such symptoms are common and frequently non-specific, which frequently contributes to diagnostic delays. Many of them may occur before gastrointestinal symptoms or appear as isolated signs, leading to underdiagnosis and untreated disease. Summary Many extraintestinal symptoms of CD are still overlooked by clinicians. Improving healthcare professionals’ awareness of these symptoms may lead to earlier diagnosis and earlier initiation of a gluten-free diet. Timely treatment can help avoid long-term complications and significantly improve patients’ prognosis and quality of life.
- Open Access
- 25 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 81
The Bidirectional Relationship Between Obstructive Sleep Apnea and Obesity – A Literature Review
Introduction and purpose Obstructive sleep apnea (OSA) is recognized as one of the most prevalent sleep-related breathing disorders worldwide, affecting up to one billion adults aged 30 to 69 years. This disorder is characterized by recurrent episodes of upper airway collapse during sleep, leading to partial (hypopnea) or complete (apnea) cessation of airflow despite ongoing respiratory effort. These events cause intermittent oxygen desaturation and fragmented sleep architecture, resulting in significant daytime symptoms and adverse health outcomes. The current review aims to elucidate the complex bidirectional relationship between obstructive sleep apnea and obesity, emphasizing the necessity of a comprehensive and integrated clinical approach for the diagnosis, treatment, and management of these intertwined conditions. A brief description of the state of knowledge A systematic literature review was performed using PubMed and MDPI databases, encompassing original research articles, systematic reviews, and meta-analyses focusing on obstructive sleep apnea, with particular attention to publications from the last twenty years. The evidence consistently supports a reciprocal association between obesity and obstructive sleep apnea. Additionally, the effect of continuous positive airway pressure (CPAP) therapy on body weight is unclear, with weight gain primarily reported in patients who have poor adherence to the treatment. Summary Due to the lack of conclusive data, future investigations should focus on delineating the hormonal and physiological mechanisms that underpin OSA–obesity interaction, optimizing CPAP treatment protocols, and developing targeted weight management strategies tailored for this high-risk patient population. Moreover, clinicians should strongly advocate for the implementation of concurrent behavioral interventions alongside CPAP therapy to mitigate the risk of therapy-associated weight gain and improve overall patient outcomes.
- 25 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 81
Open AccessThe Bidirectional Relationship Between Obstructive Sleep Apnea and Obesity – A Literature Review
Introduction and purpose Obstructive sleep apnea (OSA) is recognized as one of the most prevalent sleep-related breathing disorders worldwide, affecting up to one billion adults aged 30 to 69 years. This disorder is characterized by recurrent episodes of upper airway collapse during sleep, leading to partial (hypopnea) or complete (apnea) cessation of airflow despite ongoing respiratory effort. These events cause intermittent oxygen desaturation and fragmented sleep architecture, resulting in significant daytime symptoms and adverse health outcomes. The current review aims to elucidate the complex bidirectional relationship between obstructive sleep apnea and obesity, emphasizing the necessity of a comprehensive and integrated clinical approach for the diagnosis, treatment, and management of these intertwined conditions. A brief description of the state of knowledge A systematic literature review was performed using PubMed and MDPI databases, encompassing original research articles, systematic reviews, and meta-analyses focusing on obstructive sleep apnea, with particular attention to publications from the last twenty years. The evidence consistently supports a reciprocal association between obesity and obstructive sleep apnea. Additionally, the effect of continuous positive airway pressure (CPAP) therapy on body weight is unclear, with weight gain primarily reported in patients who have poor adherence to the treatment. Summary Due to the lack of conclusive data, future investigations should focus on delineating the hormonal and physiological mechanisms that underpin OSA–obesity interaction, optimizing CPAP treatment protocols, and developing targeted weight management strategies tailored for this high-risk patient population. Moreover, clinicians should strongly advocate for the implementation of concurrent behavioral interventions alongside CPAP therapy to mitigate the risk of therapy-associated weight gain and improve overall patient outcomes.
- Open Access
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 6 (3(47))
MULTIPLE APPLICATIONS OF COLD ATMOSPHERIC PLASMA IN MEDICINE
Background: Cold atmospheric plasma (CAP) is a partially ionized gas produced at near-room temperature and atmospheric pressure. It has gained significant interest in recent years due to its diverse biomedical applications, especially in oncology, dermatology, and wound healing. The therapeutic potential of CAP is primarily based on the generation of reactive oxygen and nitrogen species (RONS), as well as minor ultraviolet radiation. Aim: The aim of this review is to summarize current knowledge from 2020 to 2025 regarding the biological effects and clinical applications of CAP, with particular emphasis on its role in cancer treatment, dermatological conditions, and wound management. Material and methods: A literature review was conducted using the PubMed database, focusing on articles published in English between 2016 and 2025 with a particular focus on recent evidence from 2021 to 2025 that address the medical use of CAP. Studies without full text, control groups, or of poor methodological quality were excluded. Results: In oncology, CAP demonstrates selective cytotoxic effects against tumor cells by disrupting cellular signaling, inducing oxidative stress, and modulating the tumor microenvironment. Studies report efficacy in cancers such as melanoma, breast cancer, and head and neck tumors. In dermatology, CAP exhibits antimicrobial activity, enhances skin barrier repair, modulates immune responses, and improves transdermal drug delivery. In wound care, CAP supports tissue regeneration by promoting cell proliferation, angiogenesis, and the breakdown of microbial biofilms. Conclusions: CAP is a promising tool in modern medicine with broad therapeutic potential. Despite encouraging results, further research is necessary to standardize treatment protocols, ensure long-term safety, and optimize plasma devices for clinical use.
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 6 (3(47))
Open AccessMULTIPLE APPLICATIONS OF COLD ATMOSPHERIC PLASMA IN MEDICINE
Background: Cold atmospheric plasma (CAP) is a partially ionized gas produced at near-room temperature and atmospheric pressure. It has gained significant interest in recent years due to its diverse biomedical applications, especially in oncology, dermatology, and wound healing. The therapeutic potential of CAP is primarily based on the generation of reactive oxygen and nitrogen species (RONS), as well as minor ultraviolet radiation. Aim: The aim of this review is to summarize current knowledge from 2020 to 2025 regarding the biological effects and clinical applications of CAP, with particular emphasis on its role in cancer treatment, dermatological conditions, and wound management. Material and methods: A literature review was conducted using the PubMed database, focusing on articles published in English between 2016 and 2025 with a particular focus on recent evidence from 2021 to 2025 that address the medical use of CAP. Studies without full text, control groups, or of poor methodological quality were excluded. Results: In oncology, CAP demonstrates selective cytotoxic effects against tumor cells by disrupting cellular signaling, inducing oxidative stress, and modulating the tumor microenvironment. Studies report efficacy in cancers such as melanoma, breast cancer, and head and neck tumors. In dermatology, CAP exhibits antimicrobial activity, enhances skin barrier repair, modulates immune responses, and improves transdermal drug delivery. In wound care, CAP supports tissue regeneration by promoting cell proliferation, angiogenesis, and the breakdown of microbial biofilms. Conclusions: CAP is a promising tool in modern medicine with broad therapeutic potential. Despite encouraging results, further research is necessary to standardize treatment protocols, ensure long-term safety, and optimize plasma devices for clinical use.
- Open Access
- 6 August 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 44, 62830
Patellofemoral pain syndrome – a review of causes, diagnosis and management
Introduction: Patellofemoral pain syndrome (PFPS) is a common cause of anterior knee pain, especially in young and physically active individuals. It manifests itself with diffuse pain around the patella, which intensifies during flexion activities such as squatting, running or descending stairs. Despite the lack of unequivocal structural changes, PFPS can lead to chronic pain and limited joint function. Aim of the study: The aim of the study is to review current data on the pathophysiology, diagnostics (clinical and imaging) and treatment strategies for PFPS, with particular emphasis on prognosis and relapse prevention. Materials and methods: A review of the literature from the last 10 years was conducted from the PubMed, Scopus and Google Scholar databases. English and Polish-language papers on diagnostics, conservative and surgical treatment and prevention were included. State of knowledge: The main factors of PFPS are biomechanical disorders (e.g. increased Q angle, VMO weakness). Conservative treatment (physiotherapy, education, taping) is the basis. Surgical treatment is considered in resistant cases. Symptom recurrence is frequent, hence the importance of prevention. Conclusion: Effective PFPS therapy requires an individual and multifaceted approach, combining physiotherapy, education and, when necessary, surgical treatment.
- 6 August 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 44, 62830
Open AccessPatellofemoral pain syndrome – a review of causes, diagnosis and management
Introduction: Patellofemoral pain syndrome (PFPS) is a common cause of anterior knee pain, especially in young and physically active individuals. It manifests itself with diffuse pain around the patella, which intensifies during flexion activities such as squatting, running or descending stairs. Despite the lack of unequivocal structural changes, PFPS can lead to chronic pain and limited joint function. Aim of the study: The aim of the study is to review current data on the pathophysiology, diagnostics (clinical and imaging) and treatment strategies for PFPS, with particular emphasis on prognosis and relapse prevention. Materials and methods: A review of the literature from the last 10 years was conducted from the PubMed, Scopus and Google Scholar databases. English and Polish-language papers on diagnostics, conservative and surgical treatment and prevention were included. State of knowledge: The main factors of PFPS are biomechanical disorders (e.g. increased Q angle, VMO weakness). Conservative treatment (physiotherapy, education, taping) is the basis. Surgical treatment is considered in resistant cases. Symptom recurrence is frequent, hence the importance of prevention. Conclusion: Effective PFPS therapy requires an individual and multifaceted approach, combining physiotherapy, education and, when necessary, surgical treatment.